Elanco Animal Health (ELAN) Long-Term Debt Issuances (2018 - 2025)

Elanco Animal Health (ELAN) posted Long-Term Debt Issuances of $2.1 billion for Q4 2025, up 321.2% sequentially from $500.0 million in Q3 2021.

Elanco Animal Health (ELAN) Long-Term Debt Issuances (2018 - 2025) Analysis & Trends

Elanco Animal Health has reported Long-Term Debt Issuances for 5 years, with the latest figure at $2.1 billion in Q4 2025.

Quarterly Long-Term Debt Issuances changed N/A year-over-year to $2.1 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.1 billion (changed N/A YoY) and the FY2025 annual result came in at $2.1 billion, up 501.71% from the prior year.
Long-Term Debt Issuances advanced to $2.1 billion in Q4 2025 per ELAN's latest filing, from $500.0 million in the prior quarter.
Over five years, Long-Term Debt Issuances peaked at $2.1 billion in Q4 2025 and troughed at $500.0 million in Q3 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Debt Issuances (Qtr)
1	Haleon	43.85 Bn	42.88 Bn	-	-
2	Teva Pharmaceutical Industries	43.31 Bn	39.66 Bn	2.15 Bn	-
3	Zoetis	31.65 Bn	29.98 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.68 Bn	22.88 Bn	5.10 Bn	-
5	United Therapeutics	22.18 Bn	19.52 Bn	683.80 Mn	-
6	Viatris	18.82 Bn	17.94 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.70 Bn	15.31 Bn	935.80 Mn	-
8	Elanco Animal Health	12.11 Bn	11.58 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.13 Bn	9.96 Bn	-	-
10	Alkermes	8.21 Bn	7.55 Bn	397.90 Mn	-

Download Data